Latest News about ABBV
Recent news which mentions ABBV
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
From Motley Fool
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
December 19, 2023
From InvestorPlace
7 ‘Bulletproof’ Stocks to Buy Ahead of a Wild New Year
December 19, 2023
Tags
NYSE:WM,NYSE:PEG,NYSE:V,NYSE:MCD,NASDAQ:SBUX,NYSE:ABBV,NASDAQ:MSFT,NASDAQ:AAPL,NYSE:KR
MSFT
Market News
From InvestorPlace
Better Income Stock: AT&T or AbbVie?
December 17, 2023
From Motley Fool
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
From InvestorPlace
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
From Benzinga
Decoding AbbVie's Options Activity: What's the Big Picture?
December 14, 2023
Tickers
ABBV
From Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
Tags
NYSE:NKE,NYSE:DIS,NYSE:F,NASDAQ:HAS,NYSE:OXY,NYSE:ABBV,NASDAQ:IMGN,NASDAQ:CERE,NYSE:BA,NYSE:C
CERE
IMGN
From InvestorPlace
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 13, 2023
Tickers
ABBV
From Benzinga
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
From InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
From Benzinga
From Motley Fool
From Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
From InvestorPlace
From Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
From Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
December 09, 2023
From Motley Fool
Better Dividend Stock: AbbVie vs. Medical Properties Trust
December 09, 2023
From Motley Fool
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
December 08, 2023
From Motley Fool
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
From Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
From Benzinga
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.